All markets
Will Viking Therapeutics be acquired before 2027?
13%chance
- Yes12.5%
Outcomes
- Yes13%
12.5¢ per share
- No88%
87.5¢ per share
Order book
Trade YesMidpoint 12.5¢Spread 1¢
Bids
| Price | Shares | Total |
|---|---|---|
| 12¢ | 201.33 | $24.16 |
| 11¢ | 236 | $25.96 |
| 10¢ | 2,304.75 | $230.48 |
| 9¢ | 38 | $3.42 |
| 8¢ | 196.4 | $15.71 |
| 7¢ | 428.8 | $30.02 |
| 5¢ | 1,000 | $50.00 |
| 4¢ | 1,025 | $41.00 |
| 3¢ | 341.73 | $10.25 |
| 2¢ | 5,000 | $100.00 |
Asks
| Price | Shares | Total |
|---|---|---|
| 13¢ | 131.78 | $17.13 |
| 14¢ | 1,328.55 | $186.00 |
| 15¢ | 40.01 | $6.00 |
| 16¢ | 1,535 | $245.60 |
| 17¢ | 60 | $10.20 |
| 18¢ | 10 | $1.80 |
| 27¢ | 10.95 | $2.96 |
| 30¢ | 14 | $4.20 |
| 53¢ | 50 | $26.50 |
| 95¢ | 6.49 | $6.17 |
Rules
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire the listed company by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. Mergers where the listed company is subsumed by another entity will count toward a "Yes" resolution. An announced agreement between the listed company and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed. The primary resolution source for this market is official information from the listed company and/or its leadership; however, a consensus of credible reporting will also be used.